Vadsp Pharma Care Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
as on 23-10-2024
- Paid Up Capital ₹ 5.50 M
as on 23-10-2024
- Company Age 36 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.40 Cr
as on 23-10-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets %
(FY 2023)
About Vadsp Pharma Care
The Corporate was formerly known as Unison Drugs Pvt Ltd. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 M and a paid-up capital of Rs 5.50 M.
The company has closed loans amounting to ₹4.40 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vijay Uppal and Anand Uppal serve as directors at the Company.
- CIN/LLPIN
U24232CH1988PTC008335
- Company No.
008335
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vadsp Pharma Care?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Uppal  | Managing Director | 25-Jul-1992 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anand Uppal | Director | 24-Nov-2004 | Current |
Financial Performance of Vadsp Pharma Care.
Vadsp Pharma Care Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vadsp Pharma Care?
In 2023, Vadsp Pharma Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chemzin Graphics Private LimitedActive 4 years 4 monthsVijay Uppal and Anand Uppal are mutual person
- Biotrendz Medicament Private LimitedActive 4 years 10 months
Vijay Uppal and Anand Uppal are mutual person
- Chemzin Biotox Research Institute Private LimitedActive 1 year 3 months
Vijay Uppal and Anand Uppal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 03 Mar 2016 | ₹2.00 Cr | Satisfied |
Dena Bank Creation Date: 04 Jun 2014 | ₹1.00 Cr | Satisfied |
Punjab And Sind Bank Creation Date: 07 Aug 2010 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Vadsp Pharma Care?
Unlock and access historical data on people associated with Vadsp Pharma Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vadsp Pharma Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vadsp Pharma Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
